Stay updated on Secured Access to Nivolumab for Rare Cancers Clinical Trial
Sign up to get notified when there's something new on the Secured Access to Nivolumab for Rare Cancers Clinical Trial page.

Latest updates to the Secured Access to Nivolumab for Rare Cancers Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been pushed back from June 2025 to July 2025.SummaryDifference0.8%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check35 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check64 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check78 days agoChange DetectedThe web page has undergone significant changes, including the removal of detailed descriptions of a Phase 2 clinical study for nivolumab monotherapy and the addition of collaborators and a new revision number. The core content regarding the study's design and patient enrollment criteria has been largely deleted.SummaryDifference50%
- Check85 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to Secured Access to Nivolumab for Rare Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Secured Access to Nivolumab for Rare Cancers Clinical Trial page.